A Cochrane review bolsters scientists’ advice that ivermectin should not be used against the disease outside of clinical trials, while a study claiming to have found beneficial effects in patients was withdrawn following allegations of data manipulation.

Few peer-reviewed clinical papers on the pandemic contained original data, and many of those that did had poor experimental design.

Patients’ viral loads are highest within five days of their first symptoms, emphasizing the need to isolate early to prevent transmission.

In clinical studies worldwide, researchers are testing the possibility that supplements of the vitamin could prevent or decrease the severity of SARS-CoV-2 infections.

A meta-analysis of more than 80 studies from the past four decades finds weak evidence to support the use of medicinal cannabis to treat anxiety, depression, and other mental health disorders.

A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.

The controversial antiviral drug earns better marks in the most recent analysis of the evidence. 

The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  

After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.

A new meta-analysis finds that resveratrol, currently marketed as a life-extending health supplement, may have a negligible effect on lifespan in humans.

The FDA and NIH dispute reports that clinical trial data is being under-reported.

Scientists and their many hats

Extra inches may mean a higher chance of getting ovarian cancer.

Pooled data from H5N1 bird flu studies suggests that the World Health Organization may be underestimating infection and overestimating fatality.